The Econophy™ Group's focus is biotech, particularly special situations, related to innovative technology diagnostics, that involve nuclear medicine and molecular imaging.
Our global strategic partner relationships include pharma, life sciences, CROs, business development, commercialization, distribution, and capital markets.
We prefer biotech ventures that have successfully completed their Phase I & II clinical trials with proven efficacy. Each target company is now positioned to enter its Phase III trial for FDA approval.
Ideal candidates are those whose technology has clearly defined capability, scalability, adaptability, and versatility that will improve the patient care treatment process by reducing costs, and the patient treatment process time. Inclusively, the technology has proven itself to be safe, non-invasive, and far-reaching, as a solution provider.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 70 W Madison St, Chicago,illinois,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://econophy.com/
- HQ
- Chicago, Illinois
The Econophy Group Llc Questions
The Econophy Group Llc's website is http://econophy.com/
The Econophy Group Llc's LinkedIn profile is https://www.linkedin.com/company/econophygroupllc
The Econophy Group Llc has
2 employees.
View email and phone details for 2
employees at The Econophy Group Llc.
The Econophy Group Llc's industry is
Investment Management
The Econophy Group Llc's top competitors are
Crescent Pharma Ltd,
Mindimmune Therapeutics, Inc.,
Clinexel,
Talent Q Global,
Ajna Therapeutics,
Kp-Morgan Group,
Upsite Clinical,
Proofpilot,
Continuum India Llp,
Bioasia 2025.
The Econophy Group Llc's categories are Investment Management
The Econophy Group Llc's founding year is 2019
